0001562180-22-003494.txt : 20220420
0001562180-22-003494.hdr.sgml : 20220420
20220420175707
ACCESSION NUMBER: 0001562180-22-003494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220418
FILED AS OF DATE: 20220420
DATE AS OF CHANGE: 20220420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hill, Mitch C.
CENTRAL INDEX KEY: 0001644989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 22839171
MAIL ADDRESS:
STREET 1: 1009 TENNYSON DRIVE
CITY: SOUTHLAKE
STATE: TX
ZIP: 76902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-04-18
false
0001531048
Inari Medical, Inc.
NARI
0001644989
Hill, Mitch C.
C/O INARI MEDICAL, INC.
6001 OAK CANYON, SUITE 100
IRVINE
CA
92618
false
true
false
false
Chief Financial Officer
Common Stock
2022-04-18
4
M
false
7500.00
0.457
A
87062.00
D
Common Stock
2022-04-18
4
S
false
3921.00
86.13
D
83141.00
D
Common Stock
2022-04-18
4
S
false
2179.00
86.75
D
80962.00
D
Common Stock
2022-04-18
4
S
false
600.00
88.79
D
80362.00
D
Common Stock
2022-04-18
4
S
false
800.00
89.54
D
79562.00
D
Common Stock
1600.00
I
By Spouse
Stock Options (Right to buy)
0.457
2022-04-18
4
M
false
7500.00
0.457
D
2029-04-23
Common Stock
7500.00
221977.00
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021
This transaction was executed in multiple trades at prices ranging from $85.54 to $86.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $86.54 to $87.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $88.19 to $89.10 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $89.21 to $89.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Options vested with respected with 25% of the underlying shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
2022-04-20